This episode of ‘Health Management Voices' is recorded as part of the European Health Management Conference podcast series, created to support current and future conference participants in navigating the EHM Conference experience. The series aim to provide practical guidance, particularly around the abstract submission and presentation process, and to help researchers and health management professionals make the most of their engagement with the Conference.

In this episode, we focus on preparing and submitting high-quality abstracts and presentations for the EHMC.

Our guest, Dr Marius Ungureanu, Chair of the Department of Public Health, Director of the Centre for Health Workforce Research and Policy from Babes-Bolyai University Romania, member of the EHMA Governing Board spoke to EHMA Executive Director Ms Federica Margheri, shared his perspective from reviewing hundreds of conference abstracts. Together, we explore why submitting an abstract to EHMA is a valuable opportunity, what defines a strong and competitive abstract, and how authors can effectively balance technical requirements with a clear and compelling research message.

The conversation also provides a behind-the-scenes look at the EHMA abstract review process, discusses how to align submissions with conference themes, and offers practical advice for researchers who may feel uncertain about whether their work is ‘ready’ to submit.

Drawing on expert experience from the review process, the discussion offers practical insights to support researchers at all career stages, from PhD students and early-career academics to more experienced scholars.

This episode of Health Management Voices is jointly hosted by EHMA and the TRANSiTION EU Project. Learn more about the TRANSiTION Project and its mission: https://www.europeancancer.org/hpv/impact/resource/transition.html

In this episode, Grant Carroll, Chief Pharmacist, National Cancer Information System, Ireland, joins a discussion hosted by the European Health Management Association and TRANSiTION Project to explore how digital tools are being implemented in oncology care, the training approaches supporting healthcare professionals, and the broader impact of digital transformation on cancer services across Ireland.

Featuring expert insights from Mr Carroll, the conversation highlights the strategic development of the National Cancer Information System in Ireland, the challenges of rolling out digital tools across multiple hospitals, and the critical role of targeted training in equipping healthcare professionals to confidently adopt new technologies.

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.

This episode of Health Management Voices is jointly hosted by EHMA and the TRANSiTION EU Project. Learn more about the TRANSiTION Project and its mission : https://www.europeancancer.org/hpv/impact/resource/transition.html

In this episode, Dr Zisis Kozlakidis, Head, Laboratory Services and Biobanking, World Health Organization, International Agency for Research on Cancer, joins a discussion hosted by the European Health Management Association and TRANSiTION Project to explore the ethical, legal, and governance challenges surrounding the digitalisation of oncology care, with a focus on the training gaps that limit progress across Europe.

Featuring expert insights from Dr. Kozlakidis, the conversation highlights how context-specific, ethically grounded training can support a safer and more effective digital transformation in cancer care.

For any questions related to his contribution, feel free to reach out to Dr. Kozlakidis directly via kozlakidisz@iarc.who.int

Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.